Geographic difference in outcomes of congenital toxoplasmosis

Pediatric Infectious Disease Journal

Volumn 30, Issue 9, 2011, Pages 816-817

  Vasconcelos Santos, Daniel Vitor ^a   Andrade, Gláucia M Queiroz ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIORETINOPATHY; CONGENITAL TOXOPLASMOSIS; DISEASE SEVERITY; EUROPE; HUMAN; LETTER; NEWBORN SCREENING; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RECURRENT DISEASE; SOUTH AMERICA; TOXOPLASMA GONDII; TREATED CONGENITAL TOXOPLASMOSIS; VISION;

EID: 80051953016     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31822426a6     Document Type: Letter

References (6)

1. Peyron F, Garweg JG, Wallon M, et al. Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance. Pediatr Infect Dis J. 2011;30:597-600.
2. Gilbert RE, Freeman K, Lago EG, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2:e277.
3. Morisset S, Peyron F, Lobry JR, et al. Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America. Microbes Infect. 2008;10:742-747.
4. Vasconcelos-Santos DV, Machado Azevedo DO, Campos WR, et al. Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology. 2009;116:2199-205 e1.
5. Sauer A, de la Torre A, Gomez-Marin J, et al. Prevention of retinochoroiditis in congenital toxoplasmosis: Europe Versus South America. Pediatr Infect Dis J. 2011;30:601-603.
6. Roizen N, Kasza K, Karrison T, et al. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies. Pediatrics. 2006;118:e379-e390. (Pubitemid 46090508)